STARD7 could be an immunological and prognostic biomarker: from pan-cancer analysis to hepatocellular carcinoma validation
STARD7 has the potential to function as a crucial prognostic biomarker and exhibit correlation with tumor immunity in various types of human cancers. The implications of our findings extend to informing cancer immune-therapy and promoting the advancement of precision immune-oncology.
Authors
- Weili Mao (ORCID: https://orcid.org/0000-0001-5000-5895)
- Jie Hu (ORCID: https://orcid.org/0000-0002-6137-9064)
- Kaili Mao (ORCID: https://orcid.org/0009-0001-1556-4365)
- Huayu Sun (ORCID: https://orcid.org/0000-0002-6532-7018)
- Songyang Zhong
- Jiang Qiu (ORCID: https://orcid.org/0009-0007-1910-4028)
Institutions
- Wenzhou Medical University (CN)
- Quzhou City People's Hospital (CN)
- Quzhou University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1007/s12672-024-01434-x
- Citations
- 5
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.09